Improving in the Fasting, but Not the Postprandial, Glucose Level is Associated with Reduction of Plasma d-ROMs Level in Patients with Type 2 Diabetes
Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. Methods: As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission....
Saved in:
Published in | Journal of Nippon Medical School Vol. 80; no. 3; pp. 200 - 210 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Medical Association of Nippon Medical School
2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. Methods: As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. Results: The second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. Conclusions: This study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes. |
---|---|
AbstractList | AIMSThis study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. METHODSAs the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. RESULTSThe second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. CONCLUSIONSThis study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes. This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. The second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. This study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes. Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. Methods: As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. Results: The second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. Conclusions: This study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes. |
Author | Sekimizu, Ken-ichi Ohara, Makoto Motoyama, Masayuki Ishii, Kazuhito Suzuki, Tatsuya Mizuno, Kyoichi Sawai, Keisuke Oba, Kenzo Watanabe, Kentaro Nakano, Hiroshi |
Author_xml | – sequence: 1 fullname: Ohara, Makoto organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 2 fullname: Watanabe, Kentaro organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 3 fullname: Suzuki, Tatsuya organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 4 fullname: Sekimizu, Ken-ichi organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 5 fullname: Motoyama, Masayuki organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 6 fullname: Ishii, Kazuhito organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 7 fullname: Sawai, Keisuke organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 8 fullname: Nakano, Hiroshi organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 9 fullname: Oba, Kenzo organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School – sequence: 10 fullname: Mizuno, Kyoichi organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23832404$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kUlP3EAQhVuIiC2cco_6GCl40ovXSyREAkGahBGCs1XuLjM9srsHV5uIP8LvxTDDnGr76h3eO2b7Pnhk7IsUM6kK9WPle5qVYqaE2GNHUqdFolNR7b_3WZLmRX7IjolWQmidZfkBO1S61CoV6RF7ue7XQ3hy_oE7z-MS-SVQnMYz3oyR_wvxfbkIFNcDeOugO-NX3WgCIZ_jE3bcET8nCsZBRMv_u7jkt2hHE13wPLR80QH1wG1ye_OXPn48X0B06CNtPu6e18gV_-WgwYj0mX1qoSM83dYTdn_5--7iTzK_ubq-OJ8nJi1kTIoMRFaVqkEEm9vWCqhKnatGaRCVNKIAaSFHpVtps1RjlbcmN9nki250WegT9m2jO5nwOCLFundksOvAYxiplrqqRFYKkU7o9w1qhkA0YFuvB9fD8FxLUb8FUb8FUZeinoKY6K9b4bHp0e7YD-cn4OcGWFGEB9wBMERnOtyJ6a3i7mCWMNTo9Sv6dJ00 |
CitedBy_id | crossref_primary_10_1016_j_ajem_2020_08_059 |
Cites_doi | 10.1007/s13340-010-0006-7 10.1016/S0140-6736(98)00090-7 10.1186/1476-511X-8-41 10.1385/ENDO:29:1:143 10.1016/S0045-6535(99)00296-9 10.1046/j.1365-2362.30.s2.2.x 10.1016/S0168-8227(01)00353-9 10.1161/ATVBAHA.107.152835 10.1074/jbc.R400019200 10.2337/diacare.19.3.257 10.1111/j.1447-0594.2005.00282.x 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4 10.1016/S0140-6736(98)12131-1 10.1210/jc.2005-1566 10.1161/hc0502.103333 10.2337/db08-0063 10.5551/jat.E538 10.1111/j.1447-0594.2008.00465.x 10.1152/ajpheart.01332.2008 10.1016/0002-8703(87)90635-1 10.1056/NEJM199505043321804 10.2337/dc08-1671 10.5551/jat.E265 10.1007/s00125-009-1574-6 10.1016/j.ejphar.2011.02.044 10.1001/jama.295.14.1681 10.1038/414813a 10.1016/j.freeradbiomed.2010.09.006 10.1111/j.1365-2265.2007.03099.x 10.1016/0026-0495(94)90039-6 10.1016/j.bbrc.2006.09.039 10.1111/j.1464-5491.2005.01647.x 10.1111/j.1463-1326.2009.01037.x 10.1177/193229681100500112 10.2337/diacare.28.10.2465 10.1056/NEJM199309303291401 10.2337/diabetes.54.6.1615 10.2337/diacare.26.3.881 10.1016/j.archger.2009.09.022 10.1007/s00125-004-1334-6 10.1507/endocrj.K11E-114 10.1016/S0300-483X(00)00231-6 10.1016/j.atherosclerosis.2010.04.024 10.1007/s11745-011-3539-z 10.1016/j.diabres.2010.11.030 |
ContentType | Journal Article |
Copyright | 2013 by the Medical Association of Nippon Medical School |
Copyright_xml | – notice: 2013 by the Medical Association of Nippon Medical School |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1272/jnms.80.200 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1347-3409 |
EndPage | 210 |
ExternalDocumentID | 10_1272_jnms_80_200 23832404 article_jnms_80_3_80_200_article_char_en |
Genre | Journal Article |
GroupedDBID | .55 29L 2WC 53G 5GY 7.U ABDBF ABPTK AEGXH AENEX ALMA_UNASSIGNED_HOLDINGS CS3 DIK DU5 E3Z EBD EBS EJD EMOBN ESX F5P FRP GX1 JMI JSF JSH KQ8 MK0 MOJWN M~E RJT RNS RZJ SV3 TKC TR2 TUS W2D X7M XSB ~8M CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c471t-75a05982beead6dfd0a98362b23a091c07a1da6e23f1d543e96fc6c53453b3873 |
ISSN | 1345-4676 |
IngestDate | Fri Apr 12 00:46:22 EDT 2024 Fri Aug 23 01:03:41 EDT 2024 Thu May 23 23:17:58 EDT 2024 Wed Apr 05 06:07:02 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c471t-75a05982beead6dfd0a98362b23a091c07a1da6e23f1d543e96fc6c53453b3873 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jnms/80/3/80_200/_article/-char/en |
PMID | 23832404 |
PQID | 1399058004 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1399058004 crossref_primary_10_1272_jnms_80_200 pubmed_primary_23832404 jstage_primary_article_jnms_80_3_80_200_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2013-00-00 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – year: 2013 text: 2013-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Journal of Nippon Medical School |
PublicationTitleAlternate | J Nippon Med Sch |
PublicationYear | 2013 |
Publisher | The Medical Association of Nippon Medical School |
Publisher_xml | – name: The Medical Association of Nippon Medical School |
References | 44. Arcaro G, Cretti A, Balzano S, et al.: Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105: 576-582. 45. Choi SW, Benzie IF, Lam CS, et al.: Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus. Diabet Med 2005; 22: 1347-1353. 30. Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G: Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-482. 32. Ceriello A: The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000; 16: 125-132. 6. Morrow JD, Frei B, Longmire AW, et al.: Increase in circulating products of lipid peroxidation (f2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-1203. 7. Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-42354. 8. Paolisso G, D'Amore A, Volpe C, et al.: Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994; 43: 1426-1429. 26. Cesarone MR, Belcaro G, Carratelli M, et al.: A simple test to monitor oxidative stress. Int Angiol 1999; 18: 127-130. 21. Naruse R, Takebayashi K, Morita K, Aso Y, Inukai T: Comparison of effects of insulin aspart three times a day versus insulin detemir once a day on oxidative stress in patients with type 2 diabetes. Endocr J 2011; 58: 1055-1063. 15. Monnier L, Mas E, Ginet C, et al.: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687. 43. Tanaka A, Azuma K, Toyofuku Y, et al.: Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 2006; 350: 195-201. 5. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267. 22. Magata Y, Oba K, Inuzuka Y, Nakano H: Aging per se does not influence postprandial glucose levels in type 2 diabetes. Geriatr Gerontol Int 2005; 5: 146-151. 35. Nakagami T: Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004; 47: 385-394. 16. Siegelaar SE, Barwari T, Kulik W, Hoekstra JB, DeVries JH: No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. J Diabetes Sci Technol 2011; 5: 86-92. 38. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N: Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 2006; 91: 837-842. 36. The DECODE study group on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 1999; 354: 617-621. 9. Matsushima S, Kinugawa S, Yokota T, et al.: Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am J Physiol Heart Circ Physiol 2009; 297: H409-H416. 13. Bunck MC, Cornàr A, Eliasson B, et al.: One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress. Atherosclerosis 2010; 212: 223-229. 42. Monnier L, Colette C, Mas E, et al.: Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. Diabetologia 2010; 53: 562-571. 2. Evans M: The UK prospective diabetes study. Lancet 1998; 352: 1932-1933. 3. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1625. 28. Kehrer JP: The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000; 149: 43-50. 17. Hirose H, Kawabe H, Komiya N, Saito I: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009; 16: 77-82. 34. Ceriello A, Esposito K, Piconi L, et al.: Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients. Diabetes 2008; 57: 1349-1354. 47. Gianturco V, Bellomo A, D'Ottavio E, et al.: Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr 2009; 49 (Suppl 1): 129-133. 48. Yamaoka-Tojo M, Tojo T, Kosugi R, et al.: Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia. Lipids Health Dis 2009; 8: 41. 51. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ: Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005; 28: 2465-2471. 46. Kostapanos MS, Spyrou AT, Tellis CC, et al.: Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress. Lipids 2011; 46: 341-348. 50. Nagashima T, Oikawa S, Hirayama Y, et al.: Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients. Diabetes Res Clin Pract 2002; 56: 19-25. 25. Kigawa Y, Oba K, Futami-Suda S, et al.: Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients. Geriatr Gerontol Int 2008; 8: 160-165. 24. Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care 2003; 26: 881-885. 23. Monnier L: Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? Eur J Clin Invest 2000; 30 (Suppl 2): 3-11. 37. Mita T, Watada H, Shimizu T, et al.: Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol 2007; 27: 2456-2462. 49. Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L: The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance. Clin Endocrinol (Oxf) 2008; 68: 716-723. 40. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008; 51: 183-190. 31. Kotani K, Taniguchi N: The association between reactive oxygen metabolites and metabolic syndrome in asymptomatic Japanese men. J Clin Med Res 2011; 3: 247-251. 19. Seino Y, Nanjo K, Tajima N, et al.: The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20. 33. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820. 10. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-1616. 29. Seino Y, Nanjo K, Tajima N, et al.: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20. 20. Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107. 14. Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC: Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes. Eur J Pharmacol 2011; 659: 296-301. 1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986. 4. Haberland ME, Fogelman AM: The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J 1987; 113: 573-577. 18. Kamezaki F, Yamashita K, Kubara T, et al.: Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb 2008; 15: 206-212. 11. Mori Y, Itoh Y, Obata T, Tajima N: Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes. Endocrine 2006; 29: 143-148. 27. Lindsey ME, Tarr MA: Quantisation of hydroxyl radical during Fenton oxidation following a single addition of iron and peroxide. Chemosphere 2000; 41: 409-417. 41. Siegelaar SE, Kulik W, van Lenthe H, Mukherjee R, Hoekstra JB, Devries JH: A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress. Diabetes Obes Metab 2009; 11: 709-714. 12. Chakraborty A, Chowdhury S, Bhattacharyya M: Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Res Clin Pract 2011; 93: 56-62. 39. Raz I, Wilson PW, Strojek K, et al.: Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 2009; 32: 381-386. 44 45 46 47 48 49 50 51 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 |
References_xml | – ident: 29 doi: 10.1007/s13340-010-0006-7 – ident: 2 doi: 10.1016/S0140-6736(98)00090-7 – ident: 48 doi: 10.1186/1476-511X-8-41 – ident: 11 doi: 10.1385/ENDO:29:1:143 – ident: 27 doi: 10.1016/S0045-6535(99)00296-9 – ident: 23 doi: 10.1046/j.1365-2362.30.s2.2.x – ident: 50 doi: 10.1016/S0168-8227(01)00353-9 – ident: 37 doi: 10.1161/ATVBAHA.107.152835 – ident: 7 doi: 10.1074/jbc.R400019200 – ident: 31 – ident: 5 doi: 10.2337/diacare.19.3.257 – ident: 22 doi: 10.1111/j.1447-0594.2005.00282.x – ident: 32 doi: 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4 – ident: 36 doi: 10.1016/S0140-6736(98)12131-1 – ident: 38 doi: 10.1210/jc.2005-1566 – ident: 26 – ident: 44 doi: 10.1161/hc0502.103333 – ident: 34 doi: 10.2337/db08-0063 – ident: 18 doi: 10.5551/jat.E538 – ident: 25 doi: 10.1111/j.1447-0594.2008.00465.x – ident: 9 doi: 10.1152/ajpheart.01332.2008 – ident: 4 doi: 10.1016/0002-8703(87)90635-1 – ident: 6 doi: 10.1056/NEJM199505043321804 – ident: 30 – ident: 39 doi: 10.2337/dc08-1671 – ident: 17 doi: 10.5551/jat.E265 – ident: 42 doi: 10.1007/s00125-009-1574-6 – ident: 14 doi: 10.1016/j.ejphar.2011.02.044 – ident: 15 doi: 10.1001/jama.295.14.1681 – ident: 33 doi: 10.1038/414813a – ident: 40 – ident: 10 doi: 10.1016/j.freeradbiomed.2010.09.006 – ident: 49 doi: 10.1111/j.1365-2265.2007.03099.x – ident: 8 doi: 10.1016/0026-0495(94)90039-6 – ident: 43 doi: 10.1016/j.bbrc.2006.09.039 – ident: 45 doi: 10.1111/j.1464-5491.2005.01647.x – ident: 41 doi: 10.1111/j.1463-1326.2009.01037.x – ident: 16 doi: 10.1177/193229681100500112 – ident: 19 doi: 10.1007/s13340-010-0006-7 – ident: 20 – ident: 51 doi: 10.2337/diacare.28.10.2465 – ident: 1 doi: 10.1056/NEJM199309303291401 – ident: 3 doi: 10.2337/diabetes.54.6.1615 – ident: 24 doi: 10.2337/diacare.26.3.881 – ident: 47 doi: 10.1016/j.archger.2009.09.022 – ident: 35 doi: 10.1007/s00125-004-1334-6 – ident: 21 doi: 10.1507/endocrj.K11E-114 – ident: 28 doi: 10.1016/S0300-483X(00)00231-6 – ident: 13 doi: 10.1016/j.atherosclerosis.2010.04.024 – ident: 46 doi: 10.1007/s11745-011-3539-z – ident: 12 doi: 10.1016/j.diabres.2010.11.030 |
SSID | ssj0033556 |
Score | 1.9608738 |
Snippet | Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs)... This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in... AIMSThis study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs)... |
SourceID | proquest crossref pubmed jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 200 |
SubjectTerms | Adult Aged Aged, 80 and over and postprandial glucose Area Under Curve Blood Glucose - metabolism daily profile of plasma glucose Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - metabolism diacron-reactive oxygen metabolites Fasting Female Humans Male Middle Aged Oxidative Stress Postprandial Period Reactive Oxygen Species Regression Analysis type 2 diabetes |
Title | Improving in the Fasting, but Not the Postprandial, Glucose Level is Associated with Reduction of Plasma d-ROMs Level in Patients with Type 2 Diabetes |
URI | https://www.jstage.jst.go.jp/article/jnms/80/3/80_200/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/23832404 https://search.proquest.com/docview/1399058004 |
Volume | 80 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Nippon Medical School, 2013, Vol.80(3), pp.200-210 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKQGgviDvlJiONpy4ltXN9RLBpoLWTWCv1LXISZ2Rdk6hxHugP4afw-ziOHTeITRq8RFUSO1HO15PvOOd8B6EDl4aJy4hjMc9zLQCFawUZ8SzfsdMk5SSetJL505l3snC-Lt3lYPCrl7XUiHicbK-tK_kfq8I-sKuskv0Hy5pJYQf8BvvCFiwM21vZeLcioLMVM1YL3aQkbsSoKIUqhSprUW1kAUsr7z_q8tSvZMaQbGnOtJG6XPSNFHTtuGQFBHvNRqn17Wxad2OMImt97VLuDZx3lldVufs6pCVA39PP3ZEvKwZAzC_Yqhlt4a6-52YVWCpLq-qiVSnK3YcAYLdwTV1jJNjGHDpvto1qyj1nom5-mBfQOV_l63zb6DFWnujL6NUPVbY65spXUwf8o2OHfWeu2kJp0NK-Z7bt3kueqFzav94fxJd6tJfFuh4H9tiM6at0z86i48XpaTQ_Ws7voLtECgzKIvOlSS2iwOE8XQsKE37oTfcH-7l3CQHABb85tmk5zvwheqANhT8qpD1CA148RvenOv3iCfppAIfzAgOysAbcIQa4YYBbu7MPt0OswYZb4OC8xjuwYQkdbMCGywwrsGEFtm5MgTuwqRESbJjgDmxP0eL4aP7pxNKNPawEuJCwfJfZUjgy5uDHvDRLbRYGwKRiQhnw18T22SRlHic0m6SuQ3noZYmXuNRxaUwDnz5De0VZ8BcIZxB-yL5J2YQkUjswBMLtJxnENR4E6iEZooPugUeV0m-JZNwLdomkXaLAlp1Yh8hXxjAn6T-1OYnqM80BWRUJTmiI3nXWi8Azy89trOBlU0dwD6HtQkDmDNFzZVYzOxBlqYTpvLzF6Fdon7Q9WOS632u0JzYNfwNMWMRvW9j9BmPPvxE |
link.rule.ids | 315,783,787,4033,27937,27938,27939 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improving+in+the+fasting%2C+but+not+the+postprandial%2C+glucose+level+is+associated+with+reduction+of+plasma+d-ROMs+level+in+patients+with+type+2+diabetes&rft.jtitle=Journal+of+Nippon+Medical+School+%3D+Nippon+Ika+Daigaku+zasshi&rft.au=Ohara%2C+Makoto&rft.au=Watanabe%2C+Kentaro&rft.au=Suzuki%2C+Tatsuya&rft.au=Sekimizu%2C+Ken-ichi&rft.date=2013&rft.eissn=1347-3409&rft.volume=80&rft.issue=3&rft.spage=200&rft.epage=210&rft_id=info:doi/10.1272%2Fjnms.80.200&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1345-4676&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1345-4676&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1345-4676&client=summon |